Key result
Percutaneous pulmonary vein stenting was successfully deployed to treat severe pulmonary vein stenosis in a 36-year-old female following surgical reconstruction with bovine pericardium.
Why the study?
Can percutaneous pulmonary vein stenting successfully treat severe pulmonary vein stenosis after surgical reconstruction with a bovine pericardial patch?
Case Report (n=1)
Can percutaneous pulmonary vein stenting successfully treat severe pulmonary vein stenosis after surgical reconstruction with a bovine pericardial patch?
Percutaneous pulmonary vein stenting can be a successful treatment for severe pulmonary vein stenosis following surgical reconstruction with a bovine pericardial patch.
Supports feasibility after bovine pericardial reconstruction; hypothesis-generating pending larger studies on durability.
A 36-year-old female underwent left lower lobectomy with left atrial and left upper pulmonary vein (LUPV) reconstruction with a bovine pericardial patch for an intrathoracic pheochromocytoma. Postoperatively, she developed shortness of breath and transesophageal echocardiography demonstrated LUPV stenosis with increased velocities. Computed tomography angiogram of the chest revealed LUPV stenosis at the left atrium ostium with an area of 39 mm 2 . Under angiographic and echocardiographic guidance, a 10 × 19 mm Omnilink Elite uncovered stent was deployed in the LUPV ostia. While reported following left atrial ablation, pulmonary vein stenting can be successful in a pulmonary vein surgically reconstructed with bovine pericardium.
No takes yet. Share an insight, caveat, or question.
Dalal et al. (2020) conducted a case report in Severe pulmonary vein stenosis after surgical reconstruction (n=1). Percutaneous pulmonary vein stenting was evaluated on Procedural success. Percutaneous pulmonary vein stenting was successfully deployed to treat severe pulmonary vein stenosis in a 36-year-old female following surgical reconstruction with bovine pericardium.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:
More from Innovations Technology and Techniques in Cardiothoracic and Vascular Surgery